Operational description of rare diseases: a reference to improve the recognition and visibility of rare diseases

被引:3
作者
Wang, Chiuhui Mary [1 ]
Whiting, Amy Heagle [1 ]
Rath, Ana [2 ]
Anido, Roberta [3 ]
Ardigo, Diego [4 ]
Baynam, Gareth [5 ]
Dawkins, Hugh [6 ]
Hamosh, Ada [7 ]
Le Cam, Yann [8 ]
Malherbe, Helen [9 ,16 ]
Molster, Caron M. [10 ]
Monaco, Lucia [11 ]
Padilla, Carmencita D. [12 ]
Pariser, Anne R. [11 ]
Robinson, Peter N. [13 ]
Rodwell, Charlotte [2 ]
Schaefer, Franz [14 ]
Weber, Stefanie [15 ]
Macchia, Flaminia [1 ]
机构
[1] Rare Dis Int, Plateforme Malad Rares, 96 Rue Didot, F-75014 Paris, France
[2] INSERM, US14 Orphanet Plateforme Malad Rares, 96 Rue Didot, F-75014 Paris, France
[3] Federac Argentina Enfermedades Poco Frecuentes, Antonino Ferrari 1044, RA-1424 Buenos Aires, Argentina
[4] Chiesi Farmaceut SpA, Via Paradigna 131-A, Parma, Italy
[5] King Edward Mem Hosp, Perth Childrens Hosp & Western Australian Register, Rare Care Ctr, Western Australian Dept Hlth, Subiaco, WA, Australia
[6] Univ Notre Dame Australia UNDA, Sch Med, 160 Oxford St, Darlinghurst, NSW, Australia
[7] Johns Hopkins Univ, Sch Med, 600 N Wolfe St,Blalock 1008, Baltimore, MD 21287 USA
[8] EURORDIS Rare Dis Europe, Plateforme Malad Rares, 96 Rue Didot, F-75014 Paris, France
[9] Rare Dis South Africa, 63 Peter Pl, Johannesburg, South Africa
[10] West Australia Dept Hlth, Off Populat Hlth Genom, Level 3,C Block,189 Royal St, East Perth, WA 6004, Australia
[11] Int Rare Dis Res Consortium IRDiRC, Paris, France
[12] Univ Philippines Manila, Coll Med, Dept Pediat, Pedro Gil St,Taft Ave, Manila 1000, Philippines
[13] Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA
[14] Heidelberg Univ, Med Fac Heidelberg, European Rare Kidney Dis Reference Network ERKNet, Neuenheimer Feld 130-3, D-69120 Heidelberg, Germany
[15] Fed Inst Drugs & Med Devices, Dept K Code Syst & Registers, Kurt Georg Kiesinger Allee 3, D-53175 Bonn, Germany
[16] North West Univ, Ctr Human Metabol, Potchefstroom, South Africa
关键词
Rare diseases; Visibility; Definition; Coding; Healthcare systems; Prevalence; Diagnosis; Social care; Research and development; Universal health coverage;
D O I
10.1186/s13023-024-03322-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Improving health and social equity for persons living with a rare disease (PLWRD) is increasingly recognized as a global policy priority. However, there is currently no international alignment on how to define and describe rare diseases. A global reference is needed to establish a mutual understanding to inform a wide range of stakeholders for actions. A multi-stakeholder, global panel of rare disease experts, came together and developed an Operational Description of Rare Diseases. This reference describes which diseases are considered rare, how many persons are affected and why the rare disease population demands specific attention. The operational description of rare diseases is framed in two parts: a core definition of rare diseases, complemented by a descriptive framework of rare diseases. The core definition includes parameters that permit the identification of which diseases are considered rare, and how many persons are affected. The descriptive framework elaborates on the impact and burden of rare diseases on patients, their caregivers and families, healthcare systems, and society overall. The Operational Description of Rare Diseases establishes a common point of reference for decision-makers across the world who strive to understand and address the unmet needs of persons living with a rare disease. Adoption of this reference is essential to improving the visibility of rare conditions in health systems across the world. Greater recognition of the burden of rare diseases will motivate new actions and policies to address the unmet needs of the rare disease community.
引用
收藏
页数:6
相关论文
共 33 条
  • [11] Barriers and Considerations for Diagnosing Rare Diseases in Indigenous Populations
    D'Angelo, Carla S.
    Hermes, Azure
    McMaster, Christopher R.
    Prichep, Elissa
    Richer, Etienne
    van der Westhuizen, Francois H.
    Repetto, Gabriela M.
    Mengchun, Gong
    Malherbe, Helen
    Reichardt, Juergen K. V.
    Arbour, Laura
    Hudson, Maui
    du Plessis, Kelly
    Haendel, Melissa
    Wilcox, Phillip
    Lynch, Sally Ann
    Rind, Shamir
    Easteal, Simon
    Estivill, Xavier
    Thomas, Yarlalu
    Baynam, Gareth
    [J]. FRONTIERS IN PEDIATRICS, 2020, 8
  • [12] Recommendations for the design of small population clinical trials
    Day, Simon
    Jonker, Anneliene Hechtelt
    Lau, Lilian Pek Lian
    Hilgers, Ralf-Dieter
    Irony, Ilan
    Larsson, Kristina
    Roes, Kit C. B.
    Stallard, Nigel
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [13] Review of 11 national policies for rare diseases in the context of key patient needs
    Dharssi, Safiyya
    Wong-Rieger, Durhane
    Harold, Matthew
    Terry, Sharon
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [14] Rarecare: A policy perspective on the burden of rare diseases on caregivers in Latin America
    Dias, Ariadne Guimaraes
    Daher, Antoine
    Ortiz, Lucy Barrera
    Carreno-Moreno, Sonia
    Hafez, H. Sylvia R.
    Jansen, Angela Marie
    Rico-Restrepo, Mariana
    Chaparro-Diaz, Lorena
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [15] Transition from child to adult health care for patients with lysosomal storage diseases in France: current status and priorities-the TENALYS study, a patient perspective survey
    Genevaz, Delphine
    Arnoux, Armelle
    Marcel, Catherine
    Brassier, Anais
    Pichard, Samia
    Feillet, Francois
    Labarthe, Francois
    Chabrol, Brigitte
    Berger, Marc
    Lapointe, Anne-Sophie
    Frigout, Yvann
    Heron, Benedicte
    Chatellier, Gilles
    Belmatoug, Nadia
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [16] Opportunities and challenges for newborn screening and early diagnosis of rare diseases in Latin America
    Giugliani, Roberto
    Castillo Taucher, Silvia
    Hafez, Sylvia
    Oliveira, Joao Bosco
    Rico-Restrepo, Mariana
    Rozenfeld, Paula
    Zarante, Ignacio
    Gonzaga-Jauregui, Claudia
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [17] How many rare diseases are there?
    Haendel, Melissa
    Vasilevsky, Nicole
    Unni, Deepak
    Bologa, Cristian
    Harris, Nomi
    Rehm, Heidi
    Hamosh, Ada
    Baynam, Gareth
    Groza, Tudor
    McMurry, Julie
    Dawkins, Hugh
    Rath, Ana
    Thaxon, Courtney
    Bocci, Giovanni
    Joachimiak, Marcin P.
    Koehler, Sebastian
    Robinson, Peter N.
    Mungall, Chris
    Oprea, Tudor I.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (02) : 77 - 78
  • [18] China has officially released its first national list of rare diseases
    He, Jiangjiang
    Kang, Qi
    Hu, Jiahao
    Song, Peipei
    Jin, Chunlin
    [J]. INTRACTABLE & RARE DISEASES RESEARCH, 2018, 7 (02) : 145 - 147
  • [19] Hivert V, 2021, Rare Dis Orphan Drugs J, V1, P3
  • [20] Challenges of developing and conducting clinical trials in rare disorders
    Kempf, Lucas
    Goldsmith, Jonathan C.
    Temple, Robert
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2018, 176 (04) : 773 - 783